VivoSeq
Other

Motion Sickness

11

Pipeline Programs↗

4

Active Trials↗

4

Companies Involved↗

Motion Sickness is an emerging landscape with 11 programs across 4 companies. The most active players are Vanda Pharmaceuticals, AstraZeneca, Repurposed Therapeutics, Inc.. 5 therapies are approved with 3 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

39/100

Pipeline Velocity

6/100

Mech. Concentration

33/100

Completion Rate

92/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

V

Vanda Pharmaceuticals

1 program

Phase 2AstraZeneca logo

AstraZeneca

1 program

Phase 2R

Repurposed Therapeutics, Inc.

3 programs

Phase 3K

Kenvue Brands

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

17

clinical trials

Completed11 · 65%
Recruiting2 · 12%
Active, not recruiting1 · 6%
Unknown status1 · 6%
Terminated1 · 6%
Not yet recruiting1 · 6%

Clinical Trials

Trial Activity

17 trials

Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Recruiting·RRepurposed Therapeutics, Inc.·Phase 2·NCT05886660·30 enrolled
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Recruiting·RRepurposed Therapeutics, Inc.·Phase 2·NCT05852730·80 enrolled
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Active, not recruiting·VVanda Pharmaceuticals·Phase 3·NCT06138613·705 enrolled
The Relationship of Balance, Proprioception, Coordination, and Reaction Time Measurements With Motion Sickness Severity in Individuals With Motion Sickness: A Cross-Sectional Study
Not yet recruiting·IIstinye University·N/A·NCT07619469·41 enrolled
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
Completed·VVanda Pharmaceuticals·Phase 3·NCT05903924·316 enrolled
Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels
Completed·FFaisal_Karmali@MEEI.HARVARD.EDU·Phase 4·NCT02136420·30 enrolled
Gynecologic Endoscopic Surgery of Female Motion Sickness Patients
Completed·SSecond Hospital of Jilin University·Phase 4·NCT06232785·66 enrolled
Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness
Completed·FFundação Educacional Serra dos Órgãos·Phase 4·NCT03755596·184 enrolled
Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Completed·VVanda Pharmaceuticals·Phase 3·NCT04327661·366 enrolled
Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Completed·VVanda Pharmaceuticals·Phase 2·NCT03772340·126 enrolled
Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness
Completed·RRepurposed Therapeutics, Inc.·Phase 3·NCT04184115·102 enrolled
Motion Sickness Medications and Vestibular Time Constant
Completed·MMedical Corps, Israel Defense Force·Phase 4·NCT03270839·54 enrolled
Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects
Completed·RRepurposed Therapeutics, Inc.·Phase 3·NCT03988530·98 enrolled
Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
Completed·UUniversity of Pittsburgh·N/A·NCT00360282·36 enrolled
The Prevention and Treatment of Nausea Associated With Motion Sickness
Completed·RRepurposed Therapeutics, Inc.·Phase 3·NCT03986905·300 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)